Medical Communications

Showing 15 posts of 6408 posts found.

shutterstock_110597087-web

What could artificial intelligence mean for pharma?

January 15, 2016 Medical Communications artificial intelligence, digital, digital pharma, medical technology, medtech, tech

With ever rising costs in research and development, the frustratingly long time spent in bringing new novel drugs to market …
Sanofi scientist

Sanofi Pasteur to join the Human Vaccines Project

January 15, 2016 Medical Communications, Research and Development Human Vaccines Project, Sanofi Pasteur, vaccines

Sanofi Pasteur has become the latest pharma company to add funding to The Human Vaccines Project – a non-profit public-private …
Takeda UK

Takeda to bring UK salesforce in-house

January 15, 2016 Medical Communications, Sales and Marketing Takeda, field sales, marketing, sales, sales reps, salesforce

Takeda UK is to bring all of its sales teams and support resources in-house and reintegrate its field salesforce into …
abbvie

AbbVie replaces retiring VP of Western Europe and Canada

January 15, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Esteban Plata, Pascale Richetta

AbbVie has appointed Esteban Plata as vice president of Western Europe and Canada.He replaces Pascale Richetta who is retiring from …
Researcher and patient

Patient involvement ‘would improve medicines R&D’

January 15, 2016 Medical Communications, Research and Development EUPATI, Patient and Public Involvement, R&D

A new study has revealed a belief among pharma industry executives that greater involvement of patients and the public could …

Wave Healthcare Communications – Four predictions for med ed in 2016

January 14, 2016 Medical Communications medical education

These are some of the trends Wave foresees in the forthcoming year: Integration We predict there will be a greater …
FDA

FDA says no to BioMarin’s Duchenne Muscular Dystrophy drug

January 14, 2016 Medical Communications, Sales and Marketing BioMarin, Duchenne Muscular Dystrophy, FDA, Kyndrisa, drisapersen

The FDA has rejected BioMarin’s Duchenne Muscular Dystrophy (DMD) drug Kyndrisa, saying there was not enough evidence that the drug …
Hospira logo

Pfizer may sell off Hospira unit for $2 billion

January 14, 2016 Manufacturing and Production, Medical Communications, Sales and Marketing Hospira, Pfizer, injectables, pumps

Pfizer is reportedly considering selling Hospira’s infusion pump business for around $2 billion, having acquired the injectable drugs and infusion …
Ninlaro

Takeda in myeloma research drive

January 14, 2016 Medical Communications, Research and Development Ninlaro, Phase II, Takeda, Takeda oncology, eric low, ixazomib, multiple myeloma, myeloma

Takeda is funding the research charity Myeloma UK to run a Phase II study of its multiple myeloma treatment Ninlaro, …

Cell and Gene Therapy World: PCI Pharma Services expert to present on cold chain challenges

January 13, 2016 Medical Communications

Leading pharmaceutical provider PCI Pharma Services will bring its expertise to the stage at Cell and Gene Therapy World (January …
dr_robert_califf_image_via_duke_university_school_of_medicine

Senate panel approves Dr Robert Califf as FDA commissioner

January 13, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dr Robert Califf, FDA, FDA commissioner, Senate

A senate panel has approved president Obama’s nominee Dr Robert Califf to lead the FDA by a clear majority, although …
az_palmer

Three appointments in AstraZeneca’s global media relations team

January 11, 2016 Medical Communications AstraZeneca

Neil Burrows has joined as head of global media relations, following Esra Erkal-Paler’s promotion to head of global external communications.Burrows …
GSK logo

GSK explains decision to halt payments to doctors

January 8, 2016 Medical Communications, Sales and Marketing GSK, doctor payments, medical education, transparency

GSK has put into practice its pledge to halt payments to doctors to promote its products at medical seminars – …
Neil Woodford

Investment group renews calls for GSK to split

January 8, 2016 Medical Communications, Sales and Marketing GSK, Neil Woodford, investment, restructure

Multi-million pound fund manager Neil Woodford has renewed his call for GSK to break up into separate business units, amid …
Valeant logo

Why 2016 could be a make or break year for Valeant

January 8, 2016 Medical Communications, Sales and Marketing Howard Schiller, J. Michael Pearson, Michael Pearson, Valeant

This could prove a make-or-break year for Valeant.The specialist drug company begins 2016 with a reputation damaged by allegations of …
The Gateway to Local Adoption Series

Latest content